Coleman Glenn bought CRL
May 1, 2026 · Form 4 insider transaction
Coleman Glenn bought 21,112 shares of Charles River Laboratories International, Inc. at $165.78 per share, a transaction worth $3.50M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,112
Price
$165.78
Total value
$3.50M
InsiderColeman Glenn
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 1, 2026
Filing dateMay 4, 2026
Shares owned after21,112
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Unvested restricted stock units annually ratably vest on: May 1, 2027; May 1, 2028; May 1, 2029; and May 1, 2030.